Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/27/2014 | EP2768503A1 Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
08/27/2014 | EP2768502A2 Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
08/27/2014 | EP2768501A1 Method for treating capillary hemangiomas |
08/27/2014 | EP2768500A2 Treatment of cancer with tor kinase inhibitors |
08/27/2014 | EP2768499A1 Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
08/27/2014 | EP2768498A1 Therapeutic combination for the treatment of cancer |
08/27/2014 | EP2768497A1 Use of aminoacetonitrile derivatives against endoparasites |
08/27/2014 | EP2768496A1 Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof |
08/27/2014 | EP2768495A1 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof |
08/27/2014 | EP2768494A1 Dosage regimen for an s1p receptor modulator or agonist |
08/27/2014 | EP2768493A1 Phytocannabinoids for use in the treatment of breast cancer |
08/27/2014 | EP2768492A2 Compounds, compositions, and methods for reducing or eliminating bitter taste |
08/27/2014 | EP2768491A1 Inhibitors of arginase and their therapeutic applications |
08/27/2014 | EP2768489A1 Pharmaceutical compositions of resveratrol |
08/27/2014 | EP2768487A1 Sustained-release preparation |
08/27/2014 | EP2768480A1 Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo [1,4]oxazin-3-one) -6-yl]-5-fluoro-n2- [3- (methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine |
08/27/2014 | EP2768479A1 Excipients for nicotine-containing therapeutic compositions |
08/27/2014 | EP2768478A1 Paste comprising non-steroidal anti-inflammatory |
08/27/2014 | EP2768321A1 Methods and compositions for inducing satiety |
08/27/2014 | EP2768317A1 Methods and compositions for inducing satiety |
08/27/2014 | EP2768316A1 Lipid composition for the prevention or treatment of skin problems |
08/27/2014 | EP2768314A1 Composition for use in increasing insulin sensitivity and/or reducing insulin resistance |
08/27/2014 | EP2768313A1 Composition for use in the promotion of magnesium absorption and/or magnesium retention |
08/27/2014 | EP2768312A1 Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease |
08/27/2014 | EP2768311A1 Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery |
08/27/2014 | EP2768306A1 Fluorescent dyes |
08/26/2014 | US8816151 Stat5b transgenic mice and methods of use thereof |
08/26/2014 | US8816129 PTP1B inhibitors, synthesis thereof and application thereof in preparation of medicaments for treating type 2 diabetes mellitus |
08/26/2014 | US8816121 GLP-1 receptor stabilizers and modulators |
08/26/2014 | US8816119 Arylamide derivatives having antiandrogenic properties |
08/26/2014 | US8816095 Na channels, disease, and related assays and compositions |
08/26/2014 | US8816092 Indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof |
08/26/2014 | US8816091 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound |
08/26/2014 | US8816090 Benzisoxazole derivatives |
08/26/2014 | US8816089 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity |
08/26/2014 | US8816087 Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 |
08/26/2014 | US8816086 Process for preparing cannabinoid receptor ligands |
08/26/2014 | US8816085 Methylpyrrolopyridinecarboxamides |
08/26/2014 | US8816083 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof |
08/26/2014 | US8816082 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
08/26/2014 | US8816079 Amide derivative and use thereof as medicine |
08/26/2014 | US8816073 Matrix metalloproteinase inhibitors |
08/26/2014 | US8816071 Tocotrienol derivatives and associated methods |
08/26/2014 | US8816070 Triazole derivative as an HSP 90 inhibitor |
08/26/2014 | US8816065 Pharmaceutical or cosmetic composition containing nicotinic acid adenine dinucleotide phosphate or derivative thereof |
08/26/2014 | US8815970 Method of preparing polyurethane |
08/26/2014 | US8815955 Method of treating ocular disorders |
08/26/2014 | US8815954 Arginine heteromers for topical administration |
08/26/2014 | US8815953 Formulations of vitamin K analogs for topical use |
08/26/2014 | US8815952 Chlorhexadine antiseptic |
08/26/2014 | US8815951 Inhibitors of epoxide hydrolases for the treatment of inflammation |
08/26/2014 | US8815950 Pharmaceutical compositions and method of using levodopa and carbidopa |
08/26/2014 | US8815949 Composition for treating influenza a (H1N1) virus and a preparation method therefor |
08/26/2014 | US8815948 High volume and alternative methods of delivering homeopathic remedies |
08/26/2014 | US8815947 Methods of treating metabolic disorders |
08/26/2014 | US8815946 Inhibition of proliferation and fibrotic response of activated corneal stromal cells |
08/26/2014 | US8815945 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers |
08/26/2014 | US8815944 Pharmaceutical composition with gelling properties containing a tyrosine derivative |
08/26/2014 | US8815942 Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease |
08/26/2014 | US8815941 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals |
08/26/2014 | US8815940 Coumarin-chalcones as anticancer agents |
08/26/2014 | US8815939 Substituted sulfamide derivatives |
08/26/2014 | US8815938 Double compartment skincare products comprising avermectin/milbemycin compounds |
08/26/2014 | US8815937 Lipoyl compounds and their use for treating ischemic injury |
08/26/2014 | US8815935 Inhibitors of protein prenyltransferases |
08/26/2014 | US8815934 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations |
08/26/2014 | US8815933 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
08/26/2014 | US8815932 Induction of alpha helix conformations in proteins and peptides |
08/26/2014 | US8815931 Oral formulations for tetrapyrrole derivatives |
08/26/2014 | US8815930 Compounds that inhibit TRPV1 and uses thereof |
08/26/2014 | US8815929 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
08/26/2014 | US8815928 Hepatitis C virus inhibitors |
08/26/2014 | US8815926 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases |
08/26/2014 | US8815925 Use of combination preparations comprising antifungal agents |
08/26/2014 | US8815924 Heterocyclic carbonyl compounds |
08/26/2014 | US8815923 Therapeutic compounds |
08/26/2014 | US8815922 Pesticidal compositions and processes related thereto |
08/26/2014 | US8815921 Active substance combination based on trifluorobutinyl compounds and exhibiting nematicidal and insecticidal properties |
08/26/2014 | US8815920 Substituted amide compound |
08/26/2014 | US8815919 Oxadiazole derivatives |
08/26/2014 | US8815918 Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives |
08/26/2014 | US8815917 DP2 antagonist and uses thereof |
08/26/2014 | US8815916 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
08/26/2014 | US8815915 Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators |
08/26/2014 | US8815914 Positive allosteric modulators of nicotinic acetylcholine receptor |
08/26/2014 | US8815912 Wound and mucosa antiseptic based on bispyridiniumalkanes |
08/26/2014 | US8815911 Alfentanil composition for the treatment of acute pain |
08/26/2014 | US8815910 Compounds and methods for inhibiting phosphate transport |
08/26/2014 | US8815909 Diaminocyclohexane compounds and uses thereof |
08/26/2014 | US8815908 Compounds and methods for inhibiting phosphate transport |
08/26/2014 | US8815907 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
08/26/2014 | US8815906 Tyrosine kinase inhibitors |
08/26/2014 | US8815905 Propionic acids, propionic acid esters, and related compounds |
08/26/2014 | US8815903 Indole derivative and pharmacologically acceptable salt thereof |
08/26/2014 | US8815902 Tetrahydroquinoline amide M1 receptor positive allosteric modulators |
08/26/2014 | US8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors |
08/26/2014 | US8815900 Compounds and compositions for reducing lipid levels |
08/26/2014 | US8815899 Nutritional activation of telomerase in vitro and in vivo with increased safety |
08/26/2014 | US8815898 6,7-disubstituted-sioquinoline derivatives and their use |
08/26/2014 | US8815897 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof |